Ege, "Organic Chemistry" (Heath & Co) p. 98, 1984 No Month. |
Bruice, "Organic Chemistry, 2nd Ed" (Prentice Hall) pp. 53,63,1083, 1998 No Month. |
Antimicrobial Susceptibility Testing, NCCLS 3rd ed..sub.- (1991), pp. i-xii, 1-30, unnumbered. |
Barrett, "Amide Transacylation in Penicillin and Cephalosporin Derivatives," J.C.S. Perkins I 1629-1633 (1979). |
Chauvette et al., "Chemistry of Cephalosporin Antibiotics. XXI., Conversion of Penicillins to Cephalexin," J. Org. Chem. 36(9):1259-1267 (1971). |
Farina et al., "A General Route to 3-Functionalized 3-Norcephalosporins," J. Org. Che. 54:4962-5966 (1988). |
Georg, The Organic Chemistry of B-Lactams, VCH (1922) (Table of Contents). |
Goodman and Gilman editors, The Pharmacological Basis of Therapeutics, Pergamon Press (1990) Table of Contents). |
Kondo et al., "New 2"-Amino Derivatives of Arbekacin, Potent Aminoglycoside Antibiotics Against Methicillin-Resistant Staphylococcus aureus, J. Antibiotics 46(3):531-534 (1993). |
Larock, Comprenhensive Organic Transformations, VCH Publishers (1989) (Table of Contents). |
Ohki et al., "FK037. A New Parental Cephalosporin With a Broad Antibacterial Spectrum: Synthesis and Antibacterial Activity," J. Antibiotics 46:359-361 (1993). |
Remington et al., Pharmaceutical Science, Mack Publishing Company, Easton, Pennsylvania (1990) (Table of Contents Only). |
Sanders and Sanders, "Microbiological Characterization of Everninomicins B and D," Antimicrobial Agents and Chemotherapy 6(3):232-238 (1974). |
Spangler et al., "Susceptilities of Penicillin-Susceptable and -resistant Strains of Streptococcus pneumoniae to RP 59500, Vancomycin, Erythromycin, PD 131628, Sparfloxacin, Temafloxacin, Win 57273, Ofloxacin, and Ciprofloxacin," Antimicrobia Agents and Chemotherapy 36(4):856-859 (1992). |
Sum et al., "Glycylcyclines. 1. A New Generation of Potent Antibacterial Agents Through Modification of 9-Aminotetracyclines," J. Med. Chem. 37:184-188 (1994). |
Ternansky et al., "Structure-Activity Relationship within a Series of Pyrazolidinone Antibacterial Agents. 1. Effect of Nuclear Modification on In Vitro Activity,"J. Med. Chem. 36(22):3219-3223 (1993). |